The abortion pill is safe. But why should Trump let facts get in the way of his agenda? | Moira Donegan

"Mifepristone, which was approved by the FDA 25 years ago this month, has repeatedly been proven safe and effective for use terminating pregnancies in both multiple medical trials and in widespread patient use over the past quarter of a century. The report cited by Kennedy, meanwhile, comes from the Ethics and Public Policy Center a group that applies the Jewish and Christian traditions to modern law and pushes back against the extreme progressive agenda while building a consensus for conservatives and was not peer reviewed."

"The report appears to have dramatically inflated the rate of serious adverse health outcomes in patients who took mifepristone in part by seemingly conflating the bleeding that occurs in the normal course of a medication abortion with hemorrhaging, and in part by relying on unclear terminology. The Ethics and Public Policy Center report classified serious adverse events as occurring in almost 11% of mifepristone patients."

"In a meta-analysis of more than 100 studies, the vast majority found that more than 99% of people who use mifepristone have no serious complications. Mifepristone is safe. But why let the facts get in the way of the Trump administration's political agenda? The review of mifepristone marks the second time in less than a week that the Trump administration has marshalled false medical claims and junk science in an effort to constrain the freedoms of pregnant women"

Robert F. Kennedy Jr.'s health department launched a review of mifepristone based on a study from the Ethics and Public Policy Center. Mifepristone was approved by the FDA 25 years ago and has been shown safe and effective in numerous clinical trials and extensive patient use. The cited study was not peer reviewed and has faced criticism for poor methodology, lack of data transparency, conflating normal medication-abortion bleeding with hemorrhage, and unclear terminology. The study reported almost 11% serious adverse events, while rigorous peer-reviewed research finds such complications in fewer than 0.5% of users and over 99% experience no serious complications. The review aligns with recent politically driven efforts to constrain reproductive freedoms.

Read at www.theguardian.com